Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Originally developed for Alzheimer's disease research, Dihexa's remarkable neurogenic properties have attracted significant interest from the cognitive enhancement community despite limited human data
330 (Pt 2), 695699 (1998)
Importantly, these studies have not established a clear dose-response relationship, and there is no consensus on a minimum effective dose for clinically meaningful GLP-1 stimulation
It is studied in preclinical models to investigate selective lipolysis stimulation, adipocyte metabolism regulation, body composition effects, and metabolic parameter modulation
The same time frame applies to damaged and wrongly shipped items, for which the return shipping is covered by NOW
